ISPOR Investigates HEOR Research in LMICs with New Report
In a newly released report, ISPOR breaks down the state of health economics and outcomes research (HEOR) in low- and middle-income countries (LMICs). The report, entitled “Advancing HEOR in Low- and Middle-Income Countries” covers the need to better implement HEOR research in LMICs and ways to do so that will advance healthcare decision-making and patient outcomes.
Rob Abbott Appointed as CEO of ISPOR
Earlier this month, ISPOR’s Board of Directors announced they appointed a new CEO to guide the organization, Rob Abbott. Mr. Abbott has over 20 years of executive experience and lead Health Technology Assessment International as CEO and executive director. He took over the new leadership role at ISPO after the retirement of the former CEO, Nancy S. Berg.
Call for Abstracts: ISPOR 2023
ISPOR has opened abstract submissions for issue panels, workshops, and breakout sessions at its upcoming ISPOR 2023, the leading conference for health economics and outcomes research (HEOR) professionals. ISPOR 2023 takes place in Boston, MA, from May 7th-May 10th, 2023. Abstract submissions for issue panels, workshops, and breakout sessions close by December 15th, 2022. Abstracts for research and case studies open November 2nd and closes January 12th, 20223.
Conference: Virtual ISPOR Asia Pacific Summit 2022 – 20-21 September
ISPOR is hosting its Virtual ISPOR Asia Pacific Summit this upcoming September 20th and 21st. The conference will connect health [...]
ISPOR Europe 2022: Call for Abstracts – Deadline: 30 June
This November, health economics and outcomes research (HEOR) professionals from across Europe will gather at ISPOR Europe 2022 to share [...]
ISPOR Publishes HTA Deliberative Process Guidance
ISPOR – The Professional Society for Health Economics and Outcomes Research has published a new guidance on deliberative processes for [...]
Outgoing ISPOR President Isao Kamae Reflects on the Past Year
At the beginning of his final month as ISPOR President, Isao Kamae, DrPH, MD, looks back on the past year [...]
2021 ISPOR Annual Report
ISPOR has just released its annual report covering the work of ISPOR and the health economics and outcomes research (HEOR) [...]
Call for Abstracts and Reviewers: ISPOR Europe 2022
ISPOR is seeking abstracts for its upcoming ISPOR Europe 2022 conference. ISPOR Europe 2022 is the leading health economics and [...]
ISPOR Releases Quarterly News Around the Globe Publication
ISPOR has just released the latest News Across the Globe. This issue of the quarterly publication covers challenges of cost [...]
2022-2023 ISPOR Board of Directors Election – Last Chance to Vote
April 1st is the last day to submit nominations for the 2022-2023 ISPOR Board of Directors election. On the 2022 [...]
New Value in Health Article: Limitations of Conventional Cost-Effectiveness Analysis and the ISPOR Value Flower
Conventional methods of cost-effectiveness often overlook key value elements for patients. The “ISPOR Value Flower,” introduced in the 2018 ISPOR [...]
About Real-World Evidence: New ISPOR Microsite
ISPOR has announced the launch of its new microsite, “About Real-World Evidence.” This resource, produced in partnership with the Bristol [...]
News Across the Globe – New Quarterly by ISPOR
ISPOR has announced the launch of its new quarterly newsletter, News Across the Globe. The newsletter covers global health policy [...]
Call for Nominations: ISPOR Scientific Achievement and Leadership Awards
The Professional Society for Health Economics and Outcome Research (ISPOR) is seeking nominations for the 2022 ISPOR Scientific Achievement and [...]
ISPOR Europe 2021 Poster Highlights: Evidence Base Differences, Cannabis Use in Schizophrenia, and RWD Demographics
On day one of the Virtual ISPOR Europe 2021 conference (November 30th), researchers Harrison et al. presented work examining the [...]
Call for Abstracts: ISPOR 2022
Session and abstract submissions are now open for ISPOR 2022, the preeminent health economics and outcomes research conference. ISPOR 2022 [...]
“The Power of Patient Advocacy” – Value & Outcomes Spotlight Seeks Submissions
ISPOR’s journal Value & Outcomes Spotlight welcomes submissions for its January/February 2022 issue, which is themed, “The Power of Patient [...]
ISPOR Calls for Nominations for President-Elect of their 2022-2023 Board of Directors
ISPOR is seeking nominations for president-elect on the 2022-2023 ISPOR Board of Directors. In addition, there will be three vacancies [...]
ISPOR Boosts HEOR in Low & Middle-Income Countries
ISPOR pledged to promote HEOR efforts in low- to middle-income countries (LMICs) in its Strategic Plan 2024. LMICs often face [...]
PhRMA President Introduces Recipients of 2020 Challenge Award, Emphasizes Commitment to Patient Centricity
The PhRMA Foundation has expanded its vision of the value assessment framework to include health equity and patient centricity. PhRMA [...]
CEVR Director Publishes Article on Improving Data Dashboards for Drug Value Assessments
Director of the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center Peter Neumann [...]
ISPOR 2022 Issues Call for HEOR Abstracts and Seeks Research Peer Reviewers
The International Society for Pharmacoeconomics and Outcomes (ISPOR) will host its annual conference in May 2022. ISPOR has issued a call [...]
Value & Outcomes Spotlight Announces 2022 Themes
The 2022 themes of Value & Outcomes Spotlight are now available. They include submissions on global price transparency, patient advocacy, [...]
Cost-Effectiveness Analyses Fail to Consider Health Equity
Although an important tool in assessing a drug’s value, cost-effectiveness analyses (CEAs) fail to account for health equity. Important information [...]
